Page results
-
UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.
-
The spring/summer edition of Charity Matters is out now.
-
Improvements to patient care underpinned the UCLH presentations at the weekend’s European Association of Urology conference in Paris
-
University College Hospital's Outpatients department sees many patients, covering a variety of different specialties.
-
Following on from the care failures highlighted in the 2021 report, ‘No One’s Listening’, the Sickle Cell Society have taken a deeper look at sickle cell nursing care
-
A cancer treatment that is currently available to only a limited number of UK patients is to be tested at UCLH in a countrywide clinical trial to see if it causes fewer long-term side effects than standard radiotherapy.
-
A mother has written a book about her experience of having a premature baby cared for in the neonatal unit at UCLH.
-
The Psychology Team are running the next group on Navigating the Exam Period on Wednesday 14 February 2024 from 1pm to 4pm at UCLH.
-
COVID-19 vaccines are effective for most cancer patients but the level of protection offered by vaccines against infection, hospitalisation and death is lower compared with the general population and also wanes more quickly, according to a study in which UCLH participated.
-
The High Court has today ruled in favour of a judicial review claim which means children and young people may not be able to consent to hormone-blocking treatment in cases of gender dysphoria.
